Amgen (AMGN) Gross Profit (2009 - 2026)

Amgen (AMGN) has reported Gross Profit for 18 consecutive years, with $5.9 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit rose 13.38% year-over-year to $5.9 billion; the TTM figure through Mar 2026 stood at $39.1 billion (up 57.91% YoY), while the FY2025 annual figure was $35.4 billion, up 72.32% from the prior year.
• Gross Profit came in at $5.9 billion for Q1 2026 at Amgen, down from $17.6 billion in the prior quarter.
• The five-year high for Gross Profit was $17.6 billion in Q4 2025, with the low at -$1.3 billion in Q4 2022.
• Average Gross Profit over 5 years is $6.1 billion, with a median of $5.2 billion recorded in 2023.
• Across the five-year window, Gross Profit slumped 111.31% in 2022 and soared 494.72% in 2023, its largest moves.
• Year by year, Gross Profit stood at -$1.3 billion in 2022, then jumped by 494.72% to $5.1 billion in 2023, then increased by 17.51% to $6.0 billion in 2024, then jumped by 194.86% to $17.6 billion in 2025, then sank by 66.65% to $5.9 billion in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $5.9 billion, $17.6 billion, and $6.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.